Connect
MJA
MJA

New initiatives in the treatment of breast cancer

Ian N Olver
Med J Aust 2016; 205 (10): 449-450. || doi: 10.5694/mja16.01055
Published online: 21 November 2016

Better targeted therapies will reduce the burden of treatment, while improving the outcomes

With the 5-year survival for women diagnosed with breast cancer at 90%, the thrust of new initiatives is to discover whether that outcome can be either improved or achieved with less or better targeted therapy. Breast cancer was one of the first tumours to be successfully treated with a targeted therapy: trastuzumab improved outcomes for women with HER2-positive breast cancer, initially when treating metastatic disease, and then in the adjuvant therapy setting.1

  • Ian N Olver

  • Sansom Institute, University of South Australia, Adelaide, SA

Correspondence: ian.olver@unisa.edu.au

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.